Molecular Identification of Strains within the Mycobacterium abscessus Complex and Determination of Resistance to Macrolides and Aminoglycosides
Open Access
- 1 December 2023
- journal article
- research article
- Published by Polish Society of Microbiologists in Polish Journal of Microbiology
- Vol. 72 (4) , 491-506
Abstract
One of the most relevant and pathogenic groups among the rapidly growing mycobacteria (RGM) is Mycobacterium abscessus complex (MABC) that includes three subspecies: M. abscessus subsp. abscessus, M. abscessus subsp. bolletii, and M. abscessus subsp. massiliense. The aim of this study was the analysis of prevalence of MABC among other non-tuberculous mycobacteria isolated from patients in the Malopolska Region of Poland, between 2018 and 2021, as well as determination of their subspecies and molecular mechanisms of resistance to macrolides and aminoglycosides. The incidence of MABC was 5,4% (12/223). Eight strains were classified as M. abscessus subsp. abscessus, three as M. abscessus subsp. massiliense and one M. abscessus subsp. bolletii. Molecular analysis showed resistance to macrolides for eight strains of M. abscessus subsp. abscessus associated with erm(41)T28 gene mutations. One strain of M. abscessus subsp. abscessus showed resistance to macrolides (two mutations simultaneously: in erm(41)T28 and rrl genes) and aminoglycosides (point mutation in rrs gene). One strain of M. abscessus subs. bolletii was resistant to macrolides (erm(41)T28 mutation), whereas presented no mutations for aminoglycosides. M. abscessus subsp. massiliense reveal no mutations. High clarithromycin resistance of M. abscessus, determines the urgent need for susceptibility-based treatment. Molecular determination of resistance mechanisms to aminoglycosides and macrolides enables fast and accurate targeted treatment implementation.Keywords
This publication has 50 references indexed in Scilit:
- Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung DiseasesJournal of Clinical Microbiology, 2012
- Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1FEMS Immunology & Medical Microbiology, 2011
- Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessusJournal of Antimicrobial Chemotherapy, 2011
- Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl SequencingAntimicrobial Agents and Chemotherapy, 2011
- Mycobacterium abscessus: a new player in the mycobacterial fieldTrends in Microbiology, 2010
- Characterization of Mycobacteria from a Major Brazilian Outbreak Suggests that Revision of the Taxonomic Status of Members of the Mycobacterium chelonae - M. abscessus Group Is NeededJournal of Clinical Microbiology, 2009
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- Construction of Mycobacterium abscessus Defined Glycopeptidolipid Mutants: Comparison of Genetic ToolsApplied and Environmental Microbiology, 2009
- Molecular Epidemiology ofMycobacterium abscessus, with Focus on Cystic FibrosisJournal of Clinical Microbiology, 2007
- Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing MycobacteriaClinical Microbiology Reviews, 2002